Grünenthal Latin America News and Activities

Grünenthal Latin America is owned by Grunenthal. Grunenthal has a direct presence in 5 countries.

Grunenthal has 5 subsidiaries including Averitas Pharma, Grunenthal France and Grunenthal Italy.

They are in:

• Pharmaceuticals67%
• Biotechnology33%

View the org chart displaying its 6 main executives

Most searched biographies at Grünenthal Latin America

• Aldo Sterpone, President
• Leonardo Lourtau, Director, Medical
• David Perlroth, Head of Human Resources

Create your alert
to follow the executive moves at Grünenthal Latin America.

Grunenthal has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Corden Pharma has announced the acquisition of AmbioPharm  (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Grünenthal Latin America

Social media about Grünenthal Latin America

• Grünenthal Latin America on Wikipedia, Google News & Yahoo Finance
• Grünenthal Latin America on LinkedIn, X (Twitter) & YouTube